The Editor's roundtable: Advances in stem cell therapy for treatment of cardiovascular disease

American Journal of Cardiology

Volumn 110, Issue 6, 2012, Pages 807-816

  Friedewald, Vincent E ^a   Hare, Joshua M ^b   Miller, Leslie W ^c   Walpole Jr , Howard T ^d   Willerson, James T ^a,e   Roberts, William C ^f,g  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d Okyanos Heart Institute   (United States)

^e TEXAS HEART INSTITUTE   (United States)

^f BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^g BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5;

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; BONE MARROW; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL DIVISION; CELL PROLIFERATION; CORD BLOOD STEM CELL TRANSPLANTATION; CORONARY ARTERY DISEASE; EMBRYONIC STEM CELL; ETHICS; HEART FAILURE; HUMAN; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; REGENERATION; REVIEW; SARCOIDOSIS; STEM CELL TRANSPLANTATION; TERATOCARCINOMA; TURNOVER TIME;

EID: 84865455865     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.06.046     Document Type: Note

References (20)

1. B.E. Strauer, M. Brehm, T. Zeus, M. Kostering, A. Hernandez, R.V. Sorg, G. Kogler, P. Wernet Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans Circulation 106 2002 1913 1918
2. E.C. Perin, H.F. Dohmann, R. Borojevic, S.A. Silva, A.L. Sousa, C.T. Mesquita, M.I. Rossi, A.C. Carvalho, H.S. Dutra, H.J. Dohmann, G.V. Silva, L. Belem, R. Vivacqua, F.O. Rangel, R. Esporcatte, Y.J. Geng, W.K. Vaughn, J.A. Assad, E.T. Mesquita, J.T. Willerson Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure Circulation 107 2003 2294 2302
3. G. Foldes, S.E. Harding Stem Cell Therapy to Treat Heart Failure Comprehensive Biotechnology 2nd ed. 2011 Elsevier New York 407 423
4. B.-E. Strauer, G. Steinhoff 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart J Am Coll Cardiol 58 2011 1095 1104
5. A.W. Heldman, J.P. Zambrano, J. Hare Cell therapy for heart disease. Where are we in 2011? J Am Coll Cardiol 57 2011 466 468
6. B. Blum, N. Benvenisty The tumorigenicity of human embryonic stem cells Adv Cancer Res 100 2008 133 158
7. S. Aggarwal, M.F. Pittenger Human mesenchymal stem cells moderate allogenic immune cell responses Blood 105 2005 1815 1822
8. R.R. Makkar, R.R. Smith, K. Cheng, K. Malliaras, L.E.J. Thomson, D. Berman, L.S.C. Czer, L. Marban, A. Mendizabal, Johnston, S.D. Russell, K.H. Schuleri, A.C. Lardo, G. Gerstenblith, E. Marbn MD Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial Lancet 379 2012 895 904
9. D.R. Davis, R.R. Smith, E. Marbn Human cardiospheres are a source of stem cells with cardiomyogenic potential Stem Cells 28 2010 903 904
10. R. Bolli, A.R. Chugh, D. D'Amario, J.H. Laughran, M.F. Stoddard, S. Ikram, G.M. Beache, S.G. Wagner, A. Leri, T. Hosoda, F. Sanada, J.B. Elmore, P. Goichberg, D. Cappetta, N.K. Solakhi, I. Fahsah, D.G. Rokosh, M.S. Slaughter, J. Kajusta, P. Anversa Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomized phase 1 trial Lancet 378 2011 1847 1857
11. E.M. Small, J.E. Thatcher, L.B. Sutherland, H. Kinoshita, R.D. Gerard, J.A. Richardson, J.M. DiMaio, H. Sadek, K. Kuwahara, E.N. Olson Myocardin-related transcription factor-A controls myofibroblast activation and fibrosis in response to myocardial infarction Circ Res 107 2010 294 304
12. A.P. Beltrami, L. Barlucchi, D. Torella, M. Baker, F. Limana, S. Chimenti, H. Kasahara, M. Rota, E. Musso, K. Urbanek, A. Leri, J. Kajstura, B. Nadal-Ginard, P. Anversa Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
13. A.T. Askari, S. Unzek, Z.B. Popovic, C.K. Goldman, F. Forudi, M. Kiedrowski, A. Rovner, S.G. Ellis, J.D. Thomas, P.E. DiCorleto, E.J. Topol, M.S. Penn Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy Lancet 362 2003 697 703
14. V. Menon, C.A. Pearte, C.E. Buller, G. Steg, S.A. Forman, H.D. White, P.N. Marino, D.G. Katritsis, P. Caramori, R. Lasevitch, K. Loboz-Grudzien, A. Zurakowski, G.A. Lamas, J.S. Hochman Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial Eur Heart J 30 2009 183 191
15. E.C. Perin, J.T. Willerson, C.J. Pepine, T.D. Henry, S.G. Ellis, D.X. Zhao, G.V. Silva, D. Lai, J.D. Thomas, M.W. Kronenberg, A.D. Martin, R.D. Anderson, J.H. Traverse, M.S. Penn, S. Anwaruddin, A.K. Hatzopoulos, A.P. Gee, D.A. Taylor, C.R. Cogle, D. Smith, L. Westbrook, E. Handberg, R.E. Olson, C. Geither, S. Bowman, J. Francescon, S. Baraniuk, L.B. Piller, L.M. Simpson, C. Loghin, D. Aguilar, S. Richman, C. Zierold, J. Bettencourt, S.L. Sayre, R.W. Vojvodic, S.I. Skarlatos, D.J. Gordon, R.F. Ebert, M. Kwak, L.A. Moy, R.D. Simari Cardiovascular Cell Therapy Research Network Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial JAMA 307 2012 1717 1726
16. J. Tan, W. Wu, X. Xu, L. Liao, F. Zheng, S. Messinger, X. Sun, J. Chen, S. Yang, J. Cai, X. Gao, A. Pileggi, C. Ricordi Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial JAMA 307 2012 1169 1177
17. W. Wang, J.K. Lang, G. Suzuki, J.M. Canty, T. Cimato Statins enhance clonal growth of late outgrowth endothelial progenitors and increase myocardial capillary density in the chronically ischemic heart PLoS One 6 2011 e24868
18. P. Menasche Stem cell therapy for heart failure Are arrhythmias a real safety concern? Circulation 119 2009 2735 2740
19. J.M. Hare, J.H. Traverse, T.D. Henry, N. Dib, R.K. Strumpf, S.P. Schulman, G. Gerstenblith, A.N. DeMaria, A.E. Denktas, R.S. Gammon, J.B. Hermiller Jr, M.A. Reisman, G.L. Schaer, W. Sherman A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction J Am Coll Cardiol 54 2009 2277 2286
20. S. Stewart, K. MacIntyre, D.J. Hole, S. Capewell, J.J.V. McMurray More "malignant" than cancer? Five-year survival following a first admission for heart failure Eur Heart Fail 3 2001 315 322